Improved behavior and neuropsychological function in children with ROHHAD after high-dose cyclophosphamide

25Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

Abstract

Rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation (ROHHAD) is a rare, generally progressive, and potentially fatal syndrome of unclear etiology. The syndrome is characterized by normal development followed by a sudden, rapid hyperphagic weight gain beginning during the preschool period, hypothalamic dysfunction, and central hypoventilation, and is often accompanied by personality changes and developmental regression, leading to substantial morbidity and mortality. We describe 2 children who had symptomatic and neuropsychological improvement after high-dose cyclophosphamide treatment. Our experience supports an autoimmune pathogenesis and provides the first neuropsychological profile of patients with rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation.

Cite

CITATION STYLE

APA

Jacobson, L. A., Rane, S., McReynolds, L. J., Steppan, D. A., Chen, A. R., & Paz-Priel, I. (2016). Improved behavior and neuropsychological function in children with ROHHAD after high-dose cyclophosphamide. Pediatrics, 138(1). https://doi.org/10.1542/peds.2015-1080

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free